Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > RE,RE: That's pretty impressive,........
View:
Post by ISAloser247 on Sep 26, 2012 10:23am

RE,RE: That's pretty impressive,........

......You would do wonders working for the NFL public relations division ( especially after Monday night ), but I'm assuming that You consult with Darryl Cats and his  Katz Group up in Edmonton!
Comment by penguinwins on Sep 26, 2012 12:08pm
Nope sell wine in Ontario and use to be a statistician. Small private investor that likes to do his own research. I only bought into this because of the FDA approved the special protocal assessment for their phase 3 and received positive advice from the European medicines society to conduct a phase 3, plus the fact that ILJIN stated they wanted to own a bigger stake. Could kick me in the nads but ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities